藥碼
AGG01
藥名
Tirofiban 0.25 mg/mL, 50 mL/Vial
英文商品名
Aggrastat 針 12.5 mg/50 mL/Vial
中文商品名
雅瑞濃縮輸注液
螢幕名
Aggrastat 針 12.5 mg/50 mL/Vial
劑型
Inj
規格
Inj 12.5 mg/50 ml
成分
藥理分類
Platelet-Aggregation Inhibitors
健保碼
BC22606248
ATC碼
藥品圖片
外觀圖片
適應症
#高警訊藥品

抗血小板注射 Non-ST elevation acute coronary syndromes
1. To decrease the rate of thrombotic cardiovascular events in patients with non-ST-elevation acute coronary syndrome (unstable angina/non-ST-elevation myocardial infarction)
2. To prevent cardiac ischemic complications in patients receiving percutaneous coronary intervention (PCI) treatment<20211119>
#仿單變更2021
藥理
Glycoprotein IIb/IIIa Inhibitor, Antiplatelet Agent
Tirofiban is an reversible antiplatelet agent that binds to the platelet receptor glycoprotein Iib/IIIa and inhibits platelet aggregation. When given according to the recommended regimen, >90% inhibition is attained within 10 minutes after initiation.
藥動學
Platelet aggregation is inhibited as early as 5 minutes after initiation of intravenous administration; bleeding times return to normal 3 to 8 hours after discontinuation of an intravenous infusion.
禁忌症
1. Severe hypersensitivity reaction (ie, anaphylactic reaction) to tirofiban or any component of the formulation
2. History of thrombocytopenia following prior exposure to tirofiban
3. Active internal bleeding or a history of bleeding diathesis, major surgical procedure, or severe physical trauma within the previous month
4. Concomitant use of any other parenteral glycoprotein Iib/IIIa receptor 5. Other diseases: severe hypertension, stroke in previous 30 days or previous, major surgery or severe trauma within the previous month, severe liver failure<20211119>, acute pericarditis, aortic dissection
懷孕分類
B
哺乳分類
Infant risk cannot be ruled out.
副作用
Bleeding(especially with higher doses), thrombocytopenia
劑量和給藥方法
Administration:
1. Dilute: Diluted 50mL of Tirofiban solution in 200mL NS or D5W
2. Rate: 50ug/mL IV at an initial rate of 0.4ug/kg/min for 30 min followed by a continuous infusion of 0.1ug/kg/min.
Dosage:
Weight(kg) In NSTE-ACS patients Patients receiving PCI <20211119>
Loading dose:
0.4 mcg/kg/min
for 30 mins
Maintenance dose:
0.1 mcg/kg/min
Loading dose:
25 mcg/kg,
at least 3 minutes
Maintenance dose:
0.15 mcg/kg/min for 12-24 hrs,
at most 48 hrs
Loading rate(mL/hr) Maintenance rate(mL/hr) Loading rate
(mL/over 3 mins)
Maintenance rate(mL/hr)
30-37 16 4 17 6
38-45 20 5 21 7
46-54 24 6 25 9
55-62 28 7 29 11
63-70 32 8 33 12
71-79 36 9 38 14
80-87 40 10 42 15
88-95 44 11 46 16

小兒調整劑量
Treatment not recommended in children <20211119>
腎功能調整劑量
肝功能調整劑量
安定性
1. Do not allow the solution to freeze and protect it from exposure to light during storage.
2. Discard any unused diluted solution.
藥袋資訊
臨床用途
急性冠心症
主要副作用
注射部位紅腫、疼痛、噁心、發汗、頭痛等
泡製方法
儲存方式
請置於 15-30℃ 乾燥處儲存
注意事項
其他說明
急首 f3 | 藥庫 注G11
藥品外觀
顏色
形狀
剝痕
標記1
標記2
其他
健保藥價
7382
自費價
8858.4
仿單
資料庫
健保給付規定